JACQUELYN FOX: Open Payments
NPI 1861061632 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$190 in 10 payments from 5 companies in 2025. Trend: 2023 $269 · 2024 $326 · 2025 $190
Food & beverage: $190
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $103 |
| Organon LLC | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Ascensia Diabetes Care Us Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: VRAYLAR, NEXPLANON, QULIPTA, AIRSUPRA, LILETTA, GARDASIL 9.
Industry payments across UT — which companies pay providers there.
